Enhancing the Therapeutic Efficacy of Sleep Deprivation by Modafinil

PHASE2WithdrawnINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions
Depression
Interventions
DRUG

Modafinil (Vigil)

Oral application of 2 x 100 mg Modafinil each encapsulated in identical looking gelatine capsules at 12:00, 24:00 and again at 12:00 o' clock during the 40 h sleep deprivation period

DRUG

Placebo

Oral application of 2 x 100 mg Placebo each encapsulated in identical looking gelatine capsules at 12:00, 24:00 and again at 12:00 o' clock during the 40 h sleep deprivation period

Trial Locations (1)

81675

Centre for Sleep Disorders of the Department of Psychiatry and Psychotherapy, Munich

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Cephalon

INDUSTRY

lead

Technical University of Munich

OTHER

NCT00670813 - Enhancing the Therapeutic Efficacy of Sleep Deprivation by Modafinil | Biotech Hunter | Biotech Hunter